Methylphenidat Hexal

Methylphenidate Hydrochloride, the active ingredient in Methylphenidat Hexal, is a central nervous system stimulant presented as an oral dosage form for oral administration. It is indicated for the management of attention deficit hyperactivity disorder (ADHD) and narcolepsy in children, adolescents and adults.

GNH USA supplies Methylphenidat Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide through its global distribution network.

Methylphenidate Hydrochloride is a central nervous system stimulant used in the treatment of neurodevelopmental and sleep‑wake disorders. - Attention deficit hyperactivity disorder (children and adolescents): Improves concentration, reduces hyperactivity and impulsivity. - Attention deficit hyperactivity disorder (adults): Enhances focus and decreases distractibility. - Narcolepsy: Decreases excessive daytime sleepiness and promotes sustained wakefulness.

Methylphenidate Hydrochloride may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced hunger leading to weight loss. - Headache: mild to moderate cranial pain. - Stomach pain: abdominal discomfort or nausea. - Irritability: mood changes and increased agitation. - Weight loss: unintended reduction in body weight.

Serious or Rare Side Effects: - Cardiovascular events: chest pain, hypertension, or arrhythmia. - Psychotic symptoms: hallucinations or delusional thinking. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Motor or vocal tics: involuntary movements or sounds. - Priapism: prolonged, painful erection in males.

Before prescribing Methylphenidate Hydrochloride, clinicians should consider several safety measures. - Cardiovascular assessment: evaluate history of heart disease, hypertension, or arrhythmias. - Psychiatric monitoring: watch for new or worsening anxiety, depression, or psychosis. - Growth monitoring: regularly assess height and weight in pediatric patients. - Potential for abuse: use only as directed and monitor for signs of dependence. - Drug interaction review: check concomitant medications for possible interactions. - Store at room temperature: keep in the original container, protect from moisture and heat.

Methylphenidate Hydrochloride can interact with several other medicines, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: may increase cardiovascular side effects. - Antipsychotics (e.g., haloperidol): can reduce stimulant efficacy.

Moderate Interactions (Monitor Closely):\n- Selective serotonin reuptake inhibitors (SSRIs): may enhance serotonergic effects. - Antihypertensive agents: possible attenuation of blood pressure‑lowering action. - Antacids: may affect absorption of the oral formulation.